We are live on
!
Find out more
EA
Emerald Acquisition Portfolio holdings
AUM
$51.8B
This Fund
S&P 500
This Quarter
Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow
% of AUM
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.06% |
| 2 | Healthcare | 12.4% |
| 3 | Technology | 11.83% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
ASE Group
ASX
$86.6B
| $1.14M | ﹤0.01% |
193,357
-22,023
| -10% | -$130K |
|
2027
Aptevo Therapeutics
APVO
$5.42M
| – | – |
0
| – | – |
|
|
CLDT
2028
Chatham Lodging
CLDT
$620M
| $1.13M | ﹤0.01% |
58,639
-29,860
| -34% | -$642K |
|
2029
LCNB Corp
LCNB
$279M
| $1.13M | ﹤0.01% |
61,990
-5,700
| -8% | -$99.6K |
|
2030
Grupo Aval
AVAL
$5.85B
| $1.13M | ﹤0.01% |
127,686
+22,801
| +22% | +$187K |
|
2031
Ooma
OOMA
$532M
| $1.13M | ﹤0.01% |
123,942
+28,832
| +30% | +$249K |
|
|
NLSN
2032
DELISTED
Nielsen Holdings plc
NLSN
| $1.13M | ﹤0.01% |
21,005
-12,197
| -37% | -$648K |
|
|
GCP
2033
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.12M | ﹤0.01% |
39,690
-39,893
| -50% | -$1.11M |
|
|
NUTR
2034
DELISTED
Nutraceutical International Co
NUTR
| $1.12M | ﹤0.01% |
35,986
+10,383
| +41% | +$267K |
|
|
UBA
2035
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.12M | ﹤0.01% |
50,541
+2,091
| +4% | +$48.8K |
|
|
SIGM
2036
DELISTED
Sigma Designs Inc
SIGM
| $1.12M | ﹤0.01% |
144,108
| – | – |
|
2037
Brown & Brown
BRO
$22.3B
| $1.11M | ﹤0.01% |
59,060
-3,080
| -5% | -$57K |
|
|
JUNO
2038
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.11M | ﹤0.01% |
37,023
-239
| -0.6% | -$7.43K |
|
|
MORE
2039
DELISTED
Monogram Residential Trust, Inc.
MORE
| $1.11M | ﹤0.01% |
104,329
+70,002
| +204% | +$728K |
|
2040
Cable One
CABO
$211M
| $1.11M | ﹤0.01% |
1,895
-986
| -34% | -$533K |
|
2041
Trex
TREX
$4.4B
| $1.11M | ﹤0.01% |
75,380
-58,100
| -44% | -$810K |
|
|
KS
2042
DELISTED
KapStone Paper and Pack Corp.
KS
| $1.1M | ﹤0.01% |
+58,270
| New | +$935K |
|
2043
Choice Hotels
CHH
$4.92B
| $1.1M | ﹤0.01% |
24,431
-5,372
| -18% | -$258K |
|
|
VG
2044
DELISTED
Vonage Holdings Corporation
VG
| $1.1M | ﹤0.01% |
166,537
+86,184
| +107% | +$518K |
|
|
ACHN
2045
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.1M | ﹤0.01% |
135,819
-42,685
| -24% | -$363K |
|
2046
Immersion
IMMR
$219M
| $1.1M | ﹤0.01% |
134,700
-12,600
| -9% | -$93.3K |
|
2047
Super Micro Computer
SMCI
$20.2B
| $1.09M | ﹤0.01% |
468,250
+27,610
| +6% | +$61.5K |
|
2048
First Bancorp
FBNC
$2.62B
| $1.09M | ﹤0.01% |
55,260
-3,712
| -6% | -$70.9K |
|
|
MTGE
2049
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $1.09M | ﹤0.01% |
63,607
+37,012
| +139% | +$624K |
|
2050
Hilltop Holdings
HTH
$2.22B
| $1.09M | ﹤0.01% |
48,638
-133,447
| -73% | -$2.95M |
|
Similar funds
SAMC
AI
JHC
EDRAMF
PRA
TH
GF
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.